Search research articles
Contact Us
Filters
Showing results (61-70 of 166) with videos related to
Page
of 17
Sort By:
Molecular Endocrinology (Baltimore, Md.)
|
April 17, 1998
Differential use of transcription activation function 2 domain of the vitamin D receptor by 1,25-dihydroxyvitamin D3 and its A ring-modified analogs
S Peleg, C Nguyen, B T Woodard, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
October 13, 2012
Vitamin D less-calcemic analog modulates the expression of estrogen receptors, vitamin D receptor and 1α-hydroxylase 25-hydroxy vitamin D in human thyroid cancer cell lines
D Somjen, M Grafi-Cohen, G H Posner, et al.
Journal of Medicinal Chemistry
|
October 11, 2007
Low-calcemic, highly antiproliferative, 23-oxa ether analogs of the natural hormone 1 alpha,25-dihydroxyvitamin D3: design, synthesis, and preliminary biological evaluation
Kimberly S Petersen, Patrick M Dolan, Thomas W Kensler, et al.
Journal of Medicinal Chemistry
|
April 4, 1998
Design, synthesis, derivatization, and structure-activity relationships of simplified, tricyclic, 1,2,4-trioxane alcohol analogues of the antimalarial artemisinin
J N Cumming, D Wang, S B Park, et al.
Parasitology Today (Personal Ed.)
|
February 1, 1996
Second-generation antimalarial endoperoxides
S R Meshnick, C W Jefford, G H Posner, et al.
International Journal of Cell Biology
|
January 30, 2010
The response of creatine kinase specific activity in rat pituitary to estrogenic compounds and vitamin d less-calcemic analogs
D Somjen, N Mirsky, S Tamir, et al.
Journal of the American Chemical Society
|
December 20, 2011
Sequential Michael-Michael-aldol additions for easy, one-pot, 2 + 2 + 2 construction of polyfunctionalized cyclohexanols
G H Posner, S B Lu, E Asirvatham, et al.
The Journal of Organic Chemistry
|
October 2, 2001
Iron(II)-induced degradation of antimalarial beta-sulfonyl endoperoxides: evidence for the generation of potentially cytotoxic carbocations
A M Szpilman, E E Korshin, R Hoos, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
April 16, 2004
Treatment with non-hypercalcemic analogs of 1,25-dihydroxyvitamin D3 increases responsiveness to 17beta-estradiol, dihydrotestosterone or raloxifene in primary human osteoblasts
Sara Katzburg, David Hendel, Anna Waisman, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
November 30, 2010
Vitamin D metabolites and analogs induce lipoxygenase mRNA expression and activity as well as reactive oxygen species (ROS) production in human bone cell line
D Somjen, S Katzburg, M Grafi-Cohen, et al.
Page
of 17
Search research articles
Search
Showing results (61-70 of 166) with videos related to
Sort By:
Page
of 17
Molecular Endocrinology (Baltimore, Md.)
|
April 17, 1998
Differential use of transcription activation function 2 domain of the vitamin D receptor by 1,25-dihydroxyvitamin D3 and its A ring-modified analogs
S Peleg, C Nguyen, B T Woodard, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
October 13, 2012
Vitamin D less-calcemic analog modulates the expression of estrogen receptors, vitamin D receptor and 1α-hydroxylase 25-hydroxy vitamin D in human thyroid cancer cell lines
D Somjen, M Grafi-Cohen, G H Posner, et al.
Journal of Medicinal Chemistry
|
October 11, 2007
Low-calcemic, highly antiproliferative, 23-oxa ether analogs of the natural hormone 1 alpha,25-dihydroxyvitamin D3: design, synthesis, and preliminary biological evaluation
Kimberly S Petersen, Patrick M Dolan, Thomas W Kensler, et al.
Journal of Medicinal Chemistry
|
April 4, 1998
Design, synthesis, derivatization, and structure-activity relationships of simplified, tricyclic, 1,2,4-trioxane alcohol analogues of the antimalarial artemisinin
J N Cumming, D Wang, S B Park, et al.
Parasitology Today (Personal Ed.)
|
February 1, 1996
Second-generation antimalarial endoperoxides
S R Meshnick, C W Jefford, G H Posner, et al.
International Journal of Cell Biology
|
January 30, 2010
The response of creatine kinase specific activity in rat pituitary to estrogenic compounds and vitamin d less-calcemic analogs
D Somjen, N Mirsky, S Tamir, et al.
Journal of the American Chemical Society
|
December 20, 2011
Sequential Michael-Michael-aldol additions for easy, one-pot, 2 + 2 + 2 construction of polyfunctionalized cyclohexanols
G H Posner, S B Lu, E Asirvatham, et al.
The Journal of Organic Chemistry
|
October 2, 2001
Iron(II)-induced degradation of antimalarial beta-sulfonyl endoperoxides: evidence for the generation of potentially cytotoxic carbocations
A M Szpilman, E E Korshin, R Hoos, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
April 16, 2004
Treatment with non-hypercalcemic analogs of 1,25-dihydroxyvitamin D3 increases responsiveness to 17beta-estradiol, dihydrotestosterone or raloxifene in primary human osteoblasts
Sara Katzburg, David Hendel, Anna Waisman, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
November 30, 2010
Vitamin D metabolites and analogs induce lipoxygenase mRNA expression and activity as well as reactive oxygen species (ROS) production in human bone cell line
D Somjen, S Katzburg, M Grafi-Cohen, et al.
Page
of 17